Khanna, Dinesh <br/><br/>
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial.  [electronic resource] 

 -  The Journal of rheumatology  09 2016 
 - 1672-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1499-2752 
<br/><br/><label>Standard No.: </label>10.3899/jrheum.151322  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Lung Diseases, Interstitial--drug therapy<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--therapeutic use<br/>Pyridones--adverse effects<br/>Scleroderma, Systemic--complications<br/>Treatment Outcome